Article

Localized high-risk prostate cancer harbors an androgen receptor low subpopulation susceptible to HER2 inhibition

2024-02-11

Abstract excerpt

<h4>ABSTRACT</h4> Patients diagnosed with localized high-risk prostate cancer have higher rates of recurrence, and the introduction of neoadjuvant intensive hormonal therapies seeks to treat occult micrometastatic disease by their addition to definitive treatment. Sufficient profiling of baseline disease has remained a challenge in enabling the in-depth assessment of phenotypes associated with exceptional vs. poor...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 128cf56b-1fbd-5ff5-b7c0-2f7402f97447
DOI: 10.1101/2024.02.09.24302395

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Localized high-risk prostate cancer harbors an androgen receptor low subpopulation susceptible to HER2 inhibitionDOI 10.1101/2024.02.09.24302395Read

Androgen receptor (AR) heterogeneity in prostate cancer and therapy resistanceSemantic proximity Read

Determinant of aggressive phenotype in metastatic hormone sensitive prostate cancer depends on an intrinsic, highly aggressive cell cluster: Integrated single- cell and whole transcriptomic analysesSemantic proximity Read

Molecular features of exceptional response to neoadjuvant anti-androgen therapy in high-risk localized prostate cancerSemantic proximity Read

Durable Response of Enzalutamide-resistant Prostate Cancer to Supraphysiological Testosterone Is Associated with a Multifaceted Growth Suppression and Impaired DNA Damage Response Transcriptomic Program in Patient-derived XenograftsSemantic proximity Read

Drug-induced epigenomic plasticity reprograms circadian rhythm regulation to drive prostate cancer towards androgen-independenceSemantic proximity Read

Molecular features of exceptional response to neoadjuvant anti-androgen therapy in high-risk localized prostate cancerSemantic proximity Read

Extensive androgen receptor enhancer heterogeneity in primary prostate cancers underlies transcriptional diversity and metastatic potentialSemantic proximity Read

Understanding the development of enzalutamide resistance based on a functional single-cell approachSemantic proximity Read

Unveiling Prostate Cancer's Molecular Tapestry: Ethnic Disparities and Prognostic Insights from Whole-Mount Prostatectomy Tissue AnalysisSemantic proximity Read

Drug-Induced Epigenomic Plasticity Reprograms Circadian Rhythm Regulation to Drive Prostate Cancer toward Androgen IndependenceSemantic proximity Read

Linking prostate cancer cell AR heterogeneity to distinct castration and enzalutamide responsesSemantic proximity Read

Novel Androgen Receptor Coregulator GRHL2 Exerts Both Oncogenic and Antimetastatic Functions in Prostate CancerSemantic proximity Read